CARCINOGEN INDUCTION OF INFINITE LIFESPAN IN CELLS
CARCINOGEN INDUCTION OF INFINITE LIFESPAN IN CELLS
批准号:
2052232
负责人:
J JUSTIN MCCORMICK
金额:
$23.47万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-04-01 至 1996-03-31
关键词:
Bloom syndrome DNA repair Retroviridae athymic mouse cancer risk cell fusion cell transformation chemical carcinogen chemical carcinogenesis clone cells cocarcinogen congenital aplastic anemia embryo /fetus tissue /cell culture epoxides fibroblasts fibrosarcoma genetic transcription growth media host neoplasm interaction human subject human tissue karyotype laboratory mouse liver molecular oncology neoplasm /cancer immunology neoplastic growth neoplastic transformation nucleic acid hybridization oxygen tension particle counter quinolizine radiotracer tissue /cell culture tumor promoters
中文摘要
由于癌症从根本上说是一个人类问题,
理解这个过程与人类物种有关。 研究
啮齿类动物细胞恶性转化的机制
体外已经优雅地进行,并允许详细的分析
这些物种的致癌过程。 不幸的是,
培养中的人类细胞的恶性转化并不
自发发生或作为致癌物治疗的结果,
尽管包括我们小组在内的许多调查人员进行了密集的工作。
近年来,关于人类细胞恶性转化的报道很少,
已经发表的试管似乎涉及到一个很大的元素,
机会 然而,现在可以诱导人类成纤维细胞
除了一种常见的表型变化外,
转化的啮齿动物成纤维细胞的特征。 的
无限寿命(UL)特性通常被称为
“不死”是从来没有见过的。 这可能是因为啮齿动物
成纤维细胞和人成纤维细胞是根本不同的,
也许这反映了它们的寿命
物种 正如提案中所讨论的,有理由相信
这不是真的。 更有可能的是
获得UL人成纤维细胞是细胞培养的人工产物。
因此,这一建议是一个全力以赴的努力,以发展的方法,
可重复地诱导UL人成纤维细胞。 与此同时,
三个二倍体UL人成纤维细胞系,唯一已知的是,
将被用来确定各种其他变化的作用,
恶性转化的多步骤过程。
使用来自正常人和来自
对于患有布鲁姆综合症和范科尼贫血的患者,我们会尝试
来诱导具有无限寿命的细胞。 为了做到这一点,
细胞在增加氧张力的条件下诱导
致染色体断裂效应 我们还将正常的成纤维细胞
对苯并(a)芘的反式7,8-二醇-9,10-环氧化物重复
因为叙利亚仓鼠成纤维细胞暴露于这种致癌物质
导致UL。 我们将选择这些系列的治疗人群,
使用避免代谢的条件,
衰老细胞和非衰老细胞之间的合作。
在进行上述实验的同时,我们将展示三个
已经获得无限寿命的成纤维细胞系
(HUT 11、HUT、12和LGIvmyc 1)与致癌物的接触,
诱导他们获得其余的系列,
肿瘤细胞相关特征,
确定哪种特征组合赋予了他们
形成肿瘤。 我们还将确定成纤维细胞是如何
与人类纤维瘤和低度恶性肿瘤不同,
正常细胞和纤维肉瘤衍生细胞,因为它们可能
代表了恶性肿瘤的中间阶段
英文摘要
Since cancer is fundamentally a human problem, it is critical to
understand the process as related to the human species. Studies
on the mechanisms of rodent cell malignant transformation in
vitro have been elegantly carried out and allow detailed analysis
of the process of carcinogenesis in these species. Unfortunately,
the malignant transformation of human cells in culture does not
occur spontaneously or as a result of carcinogen treatment,
despite intensive work by many investigators, including our group.
The few reports of the malignant transformation of human cells in
vitro that have been published seem to involve a large element of
chance. However, it is now possible to induce human fibroblasts
to express all but one of the common phenotypic changes
characteristic of the transformed rodent fibroblasts. The
property of unlimited lifespan (UL) often referred to as
"immortality" is never seen. This may be because rodent
fibroblasts and human fibroblasts are fundamentally different,
perhaps reflecting the great difference in lifespan of these
species. As discussed in the proposal, there are reasons to believe
that this is not true. It seems much more likely that the failure
to obtain a UL human fibroblast is an artifact of cell culture.
Therefore, this proposal is an all out effort to develop methods to
reproducibly induce UL human fibroblasts. At the same time,
three diploid UL human fibroblast cell lines, the only ones know to
us, will be used to determine the role of various other changes in
the multistepped process of malignant transformation.
Using fibroblast cell lines derived from normal persons and from
patients with Bloom's syndrome and Fanconi's anemia, we will try
to induce cells with unlimited lifespans. To do so, we will grow
the cells under conditions of increased oxygen tension to induce
clastogenic effects. We will also expose normal fibroblasts
repeatedly to the anti 7,8-diol-9,10-epoxide of benzo(a)pyrene
because exposure of Syrian hamster fibroblasts to this carcinogen
led to UL. We will select these series of treated populations for
nonsenescing cells, using conditions that avoid metabolic
cooperation between senescing and nonsenescing cells.
While the above experiments are in progress we will expose three
fibroblast cell lines that have already acquired unlimited lifespan
(HUT 11, HUT, 12 and LGIvmyc1) to carcinogens in order to
induce them to acquire the rest of the series of
tumorcellrelated characteristics in a stepwise fashion and
determine which combination of traits confers on them the ability
to form tumors. We will also determine how fibroblasts derived
from human fibromas and low grade maligancies differ from
normal cells and from fibrosarcomaderived cells since they may
represent intermediates on the path to malignancy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Transformation of Infinite Life Span Human Fibroblasts
-
批准号:6747887
-
项目类别:
-
资助金额:$33.26万
-
财政年份:2003
-
负责人:J JUSTIN MCCORMICK
-
依托单位:
Transformation of Infinite Life Span Human Fibroblasts
-
批准号:6891330
-
项目类别:
-
资助金额:$33.26万
-
财政年份:2003
-
负责人:J JUSTIN MCCORMICK
-
依托单位:
Transformation of Infinite Life Span Human Fibroblasts
-
批准号:6559608
-
项目类别:
-
资助金额:$33.25万
-
财政年份:2003
-
负责人:J JUSTIN MCCORMICK
-
依托单位:
Transformation of Infinite Life Span Human Fibroblasts
-
批准号:7057856
-
项目类别:
-
资助金额:$32.48万
-
财政年份:2003
-
负责人:J JUSTIN MCCORMICK
-
依托单位:
RHO FAMILY PROTEINS AND ANCHORAGE INDEPENDENCE
-
批准号:6377446
-
项目类别:
-
资助金额:$25.06万
-
财政年份:1999
-
负责人:J JUSTIN MCCORMICK
-
依托单位:
RHO FAMILY PROTEINS AND ANCHORAGE INDEPENDENCE
-
批准号:6174134
-
项目类别:
-
资助金额:$24.46万
-
财政年份:1999
-
负责人:J JUSTIN MCCORMICK
-
依托单位:
RHO FAMILY PROTEINS AND ANCHORAGE INDEPENDENCE
-
批准号:2901636
-
项目类别:
-
资助金额:$23.73万
-
财政年份:1999
-
负责人:J JUSTIN MCCORMICK
-
依托单位:
GENETIC ANALYSIS OF TRANSFORMATION OF HUMAN FIBROBLASTS
-
批准号:2101678
-
项目类别:
-
资助金额:$19.01万
-
财政年份:1994
-
负责人:J JUSTIN MCCORMICK
-
依托单位:
PROVIDE SMALL INSTRUMENTS
-
批准号:2109365
-
项目类别:
-
资助金额:$2.41万
-
财政年份:1994
-
负责人:J JUSTIN MCCORMICK
-
依托单位:
GENETIC ANALYSIS OF TRANSFORMATION OF HUMAN FIBROBLASTS
-
批准号:2101679
-
项目类别:
-
资助金额:$19.71万
-
财政年份:1994
-
负责人:J JUSTIN MCCORMICK
-
依托单位:
GENETIC ANALYSIS OF TRANSFORMATION OF HUMAN FIBROBLASTS
-
批准号:2101677
-
项目类别:
-
资助金额:$18.21万
-
财政年份:1994
-
负责人:J JUSTIN MCCORMICK
-
依托单位:
SMALL INSTRUMENTATION GRANT
-
批准号:3523733
-
项目类别:
-
资助金额:$3.66万
-
财政年份:1993
-
负责人:J JUSTIN MCCORMICK
-
依托单位:
CARCINOGEN INDUCTION OF INFINITE LIFESPAN IN HUMAN CELLS
-
批准号:3123008
-
项目类别:
-
资助金额:$22.67万
-
财政年份:1992
-
负责人:J JUSTIN MCCORMICK
-
依托单位:
CARCINOGEN INDUCTION OF INFINITE LEFESPAN IN HUMAN CELLS
-
批准号:3123009
-
项目类别:
-
资助金额:$21.85万
-
财政年份:1992
-
负责人:J JUSTIN MCCORMICK
-
依托单位:
CARCINOGEN INDUCTION OF INFINITE LIFESPAN IN CELLS
-
批准号:2052233
-
项目类别:
-
资助金额:$24.84万
-
财政年份:1992
-
负责人:J JUSTIN MCCORMICK
-
依托单位:
CLONING OF GENES INVOLVED IN CELL IMMORTALIZATION
-
批准号:2633329
-
项目类别:
-
资助金额:$25.16万
-
财政年份:1992
-
负责人:J JUSTIN MCCORMICK
-
依托单位:
CLONING OF GENES INVOLVED IN CELL IMMORTALIZATION
-
批准号:2001455
-
项目类别:
-
资助金额:$24.43万
-
财政年份:1992
-
负责人:J JUSTIN MCCORMICK
-
依托单位:
CLONING OF GENES INVOLVED IN CELL IMMORTALIZATION
-
批准号:2855823
-
项目类别:
-
资助金额:$25.91万
-
财政年份:1992
-
负责人:J JUSTIN MCCORMICK
-
依托单位:
SMALL INSTRUMENTATION GRANT
-
批准号:3523695
-
项目类别:
-
资助金额:$3.23万
-
财政年份:1992
-
负责人:J JUSTIN MCCORMICK
-
依托单位:
CLONING OF GENES INVOLVED IN CELL IMMORTALIZATION
-
批准号:6137040
-
项目类别:
-
资助金额:$26.69万
-
财政年份:1992
-
负责人:J JUSTIN MCCORMICK
-
依托单位:
海外基金